Sulfasalazine Induced DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome with severe acute hepatitis: Case report
Open Access
- 1 January 2023
- journal article
- research article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hospital Pharmacology - International Multidisciplinary Journal
- Vol. 10 (2) , 1285-1291
Abstract
Introduction: Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome is a rare and severe form of drug induced delayed-type hypersensitivity reaction with mortality rate up to 10%. It usually manifests with skin rash, fever, lymphadenopathy, hematological abnormalities and involvement of one or more internal organs. Establishing the diagnosis is sometimes late due to variable clinical presentation. Current recommendations for therapy rely mainly on expert opinions, retrospective studies, case reports and series. Sulfasalazine was firstly synthesized in 1930 and is currently being prescribed for various inflammatory and rheumatic diseases. Case report: We present a 45-year-old patient who was prescribed sulfasalazine tablets by a rheumatologist due to reactive arthritis. In the fourth week of therapy, he developed skin rash and fever up to 39.5°C. On admission, generalized maculopapular exanthema covering over 60% of the body surface area, edema of the lower eyelids and bilateral cervical and inguinal lymphadenomegaly were registered. Laboratory findings showed leukocytosis with significant eosinophilia, lymphocytosis, elevated bilirubin values, ALT <100 U/L, while ultrasonography of the upper abdomen confirmed hepatosplenomegaly. The patient was diagnosed with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome using RegiSCAR and J-SCAR diagnostic criteria and systemic therapy with methylprednisolone at a dose of 1.5 mg/kg and other supportive therapy was applied, which resulted in complete regression of the skin changes and normalization of laboratory values. Conclusion: The authors would like to recall the occurrence of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome as a rare and potentially fatal drug reaction in which awareness of this disease is of key importance for early recognition. Identification of the offending drug followed by a prompt withdrawal and subsequent treatment is essential for decreasing disease related morbidity and mortality and thus we wish to familiarize the sulfasalazine prescribers with this syndrome.Keywords
This publication has 18 references indexed in Scilit:
- Sulfasalazine Induced DRESS Syndrome: A Review of Case ReportsBritish Journal of Medicine and Medical Research, 2016
- Comparison of Diagnostic Criteria and Determination of Prognostic Factors for Drug Reaction With Eosinophilia and Systemic Symptoms SyndromeAllergy, Asthma & Immunology Research, 2014
- Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR studyBritish Journal of Dermatology, 2013
- DRESS syndromeJournal of the American Academy of Dermatology, 2013
- DRESS syndromeJournal of the American Academy of Dermatology, 2013
- Fulminant myocarditis as a late sequela of DRESS: Two casesJournal of the American Academy of Dermatology, 2011
- Drug Reaction With Eosinophilia and Systemic SymptomsArchives of Dermatology, 2010
- Drug-Induced Hypersensitivity Syndrome With Superficial Granulomatous Dermatitis-A Novel FindingThe American Journal of Dermatopathology, 2009
- The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivationsBritish Journal of Dermatology, 2007
- Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune ResponsesAllergology International, 2006